About Centrum Diagnostyczno-Lecznicze Gammed
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centrum Diagnostyczno-Lecznicze Gammed
During the past decade, Centrum Diagnostyczno-Lecznicze Gammed conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
2016-02-24
2019-07-01
Terminated
732
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
2015-11-17
2018-01-18
Completed
160
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
2017-12-13
2018-05-22
Completed
33
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
2018-11-19
2022-06-08
Terminated
146
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Diagnostyczno-Lecznicze Gammed"
#1 collaborator was "Maria Sklodowska-Curie National Research Institute of Oncology" with 1 trials as a collaborator, "Medical University of Warsaw" with 1 trials as a collaborator, "National Center for Research and Development, Poland" with 1 trials as a collaborator, "Stowarzyszenie Pacjentów i Osób Wspierających Chorych na Guzy Neuroendokrynne" with 1 trials as a collaborator and "The Diagnostic and Therapeutic Center Gammed; Poland" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Centrum Diagnostyczno-Lecznicze Gammed
According to Clinical.Site data, the most researched conditions in "Centrum Diagnostyczno-Lecznicze Gammed" are
"Neuroendocrine Tumors" (2 trials) and "Non Functioning Entero-pancreatic Endocrine Tumour" (1 trials). Many other conditions were trialed in "Centrum Diagnostyczno-Lecznicze Gammed" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Diagnostyczno-Lecznicze Gammed
Most popular intervention types in "Centrum Diagnostyczno-Lecznicze Gammed" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "(177Lu-DOTAOTyr3)Octreotate" (1 trials), "177Lu-DOTATOC" (1 trials), "90Y DOTATATE and 177Lu DOTATATE (mix each of 50%)" (1 trials), "90Y-DOTATATE" (1 trials) and "lanreotide (Autogel formulation)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Diagnostyczno-Lecznicze Gammed
The vast majority of trials in "Centrum Diagnostyczno-Lecznicze Gammed" are
3 trials for "All" genders.
Clinical Trials Status at Centrum Diagnostyczno-Lecznicze Gammed
Currently, there are NaN active trials in "Centrum Diagnostyczno-Lecznicze Gammed".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centrum Diagnostyczno-Lecznicze Gammed,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Diagnostyczno-Lecznicze Gammed, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".